vs
Finward Bancorp（FNWD）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Finward Bancorp的1.2倍（$19.6M vs $16.5M），Finward Bancorp净利率更高（12.0% vs -177.4%，领先189.4%），Finward Bancorp同比增速更快（1.1% vs -11.5%），Finward Bancorp自由现金流更多（$9.0M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -19.1%）
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FNWD vs LAB — 直观对比
营收规模更大
LAB
是对方的1.2倍
$16.5M
营收增速更快
FNWD
高出12.6%
-11.5%
净利率更高
FNWD
高出189.4%
-177.4%
自由现金流更多
FNWD
多$32.1M
$-23.1M
两年增速更快
LAB
近两年复合增速
-19.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.5M | $19.6M |
| 净利润 | $2.0M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 11.0% | -168.5% |
| 净利率 | 12.0% | -177.4% |
| 营收同比 | 1.1% | -11.5% |
| 净利润同比 | -5.6% | -28.8% |
| 每股收益（稀释后） | $0.46 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNWDLAB
| Q4 25 | $16.5M | — | ||
| Q3 25 | $17.4M | $19.6M | ||
| Q2 25 | $16.6M | $21.8M | ||
| Q1 25 | $15.5M | $40.8M | ||
| Q4 24 | $16.3M | — | ||
| Q3 24 | $14.9M | $22.1M | ||
| Q2 24 | $14.6M | $22.5M | ||
| Q1 24 | $25.3M | $45.5M |
净利润FNWDLAB
| Q4 25 | $2.0M | — | ||
| Q3 25 | $3.5M | $-34.7M | ||
| Q2 25 | $2.2M | $-33.5M | ||
| Q1 25 | $455.0K | $-26.0M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $606.0K | $-26.9M | ||
| Q2 24 | $143.0K | $-45.7M | ||
| Q1 24 | $9.3M | $-32.2M |
毛利率FNWDLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率FNWDLAB
| Q4 25 | 11.0% | — | ||
| Q3 25 | 20.5% | -168.5% | ||
| Q2 25 | 12.7% | -118.1% | ||
| Q1 25 | 4.0% | -80.8% | ||
| Q4 24 | 16.3% | — | ||
| Q3 24 | 2.7% | -120.9% | ||
| Q2 24 | 0.9% | -134.5% | ||
| Q1 24 | 40.6% | -132.2% |
净利率FNWDLAB
| Q4 25 | 12.0% | — | ||
| Q3 25 | 20.1% | -177.4% | ||
| Q2 25 | 12.9% | -153.7% | ||
| Q1 25 | 2.9% | -63.8% | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 4.1% | -122.0% | ||
| Q2 24 | 1.0% | -203.3% | ||
| Q1 24 | 36.7% | -70.6% |
每股收益（稀释后）FNWDLAB
| Q4 25 | $0.46 | — | ||
| Q3 25 | $0.81 | $-0.09 | ||
| Q2 25 | $0.50 | $-0.09 | ||
| Q1 25 | $0.11 | $-0.07 | ||
| Q4 24 | $0.50 | — | ||
| Q3 24 | $0.14 | $-0.07 | ||
| Q2 24 | $0.03 | $-0.12 | ||
| Q1 24 | $2.17 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $174.7M | $399.7M |
| 总资产 | $2.0B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FNWDLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务FNWDLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益FNWDLAB
| Q4 25 | $174.7M | — | ||
| Q3 25 | $165.5M | $399.7M | ||
| Q2 25 | $154.3M | $424.5M | ||
| Q1 25 | $151.8M | $454.6M | ||
| Q4 24 | $151.4M | — | ||
| Q3 24 | $159.6M | $489.3M | ||
| Q2 24 | $148.6M | $510.3M | ||
| Q1 24 | $151.6M | $577.3M |
总资产FNWDLAB
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | $539.6M | ||
| Q2 25 | $2.1B | $557.0M | ||
| Q1 25 | $2.0B | $579.6M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $681.5M | ||
| Q2 24 | $2.1B | $708.7M | ||
| Q1 24 | $2.1B | $777.7M |
负债/权益比FNWDLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $9.0M | $-23.1M |
| 自由现金流率自由现金流/营收 | 54.8% | -118.1% |
| 资本支出强度资本支出/营收 | 5.2% | 4.5% |
| 现金转化率经营现金流/净利润 | 4.99× | — |
| 过去12个月自由现金流最近4个季度 | $10.6M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流FNWDLAB
| Q4 25 | $9.9M | — | ||
| Q3 25 | $1.2M | $-22.2M | ||
| Q2 25 | $4.8M | $-20.7M | ||
| Q1 25 | $-3.8M | $-30.3M | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $-3.7M | $-27.9M | ||
| Q2 24 | $2.8M | $-39.0M | ||
| Q1 24 | $-25.0K | $-62.5M |
自由现金流FNWDLAB
| Q4 25 | $9.0M | — | ||
| Q3 25 | $1.0M | $-23.1M | ||
| Q2 25 | $4.5M | $-22.6M | ||
| Q1 25 | $-4.0M | $-35.3M | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $-4.2M | $-30.1M | ||
| Q2 24 | $1.1M | $-41.0M | ||
| Q1 24 | $-736.0K | $-63.3M |
自由现金流率FNWDLAB
| Q4 25 | 54.8% | — | ||
| Q3 25 | 6.0% | -118.1% | ||
| Q2 25 | 27.0% | -103.6% | ||
| Q1 25 | -25.7% | -86.6% | ||
| Q4 24 | 41.2% | — | ||
| Q3 24 | -28.5% | -136.4% | ||
| Q2 24 | 7.6% | -182.2% | ||
| Q1 24 | -2.9% | -138.9% |
资本支出强度FNWDLAB
| Q4 25 | 5.2% | — | ||
| Q3 25 | 0.9% | 4.5% | ||
| Q2 25 | 1.7% | 8.7% | ||
| Q1 25 | 1.2% | 12.4% | ||
| Q4 24 | 18.8% | — | ||
| Q3 24 | 3.4% | 10.2% | ||
| Q2 24 | 11.2% | 8.6% | ||
| Q1 24 | 2.8% | 1.7% |
现金转化率FNWDLAB
| Q4 25 | 4.99× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | -8.37× | — | ||
| Q4 24 | 4.66× | — | ||
| Q3 24 | -6.15× | — | ||
| Q2 24 | 19.23× | — | ||
| Q1 24 | -0.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FNWD
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
